References
- Fernandez F, Levy JK, Lachar BL, et al. The management of depression and anxiety in the elderly. J Clin Psychiatry 1995; 56 Suppl 2:20–9
- Centers for Disease Control and Prevention. Suicide among older persons: United States, 1980–1992. MMWR 1996; 45(1):3–6
- Crimson ML, Dorson PG. Schizophrenia. In: DiPiro JT, Talbert RL, Yee GC, et al, eds. Pharmacotherapy: a pathophysiologic approach. 3d ed. Stamford, CT: Appleton & Lange, 1997:1381
- Wells BG, Mandos LA, Hayes PE. Depressive disorders. In: DiPiro et al, eds, 3 p 1405
- Reynolds CF 3rd. Depression: making the diagnosis and using SSRIs in the older patient. Geriatrics 1996; 51(10):28–34
- Gram L. Fluoxetine. N Engl J Med 1994; 331(20):1354–61 [Erratum, N Engl J Med 1995; 332(5):343]
- Cole JO. New directions in antidepressant therapy: a review of sertraline, a unique serotonin reuptake inhibitor. J Clin Psychiatry 1992; 53(9):333–40
- De Vane CL. Pharmacogenetics and drug metabolism of newer antidepressant agents. J Clin Psychiatry 1994; 55 (Suppl 12):38–45; discussion 46–7
- McEvoy GK, ed. AHFS Drug Information 94. Antidepressants. Bethesda, MD: American Society of Hospital Pharmacists Inc, 1994:1405
- Luvox product monograph. Marietta, GA: Solvay Pharmaceuticals, Jan 1995
- USP DI: Volumes I and II update. Rockville, MD: United States Pharmacopeial Convention Inc, 1995:700
- Serzone product monograph. Princeton, NJ: Bristol-Myers Squibb, May 1996
- Ellingrod VL, Perry PJ. Nefazodone: a new antidepressant. Am J Health Syst Pharm 1995; 52(24):2799–812
- Ellingrod VL, Perry PJ. Venlafaxine: a heterocyclic antidepressant. Am J Hosp Pharm 1994; 51(24):3033–46
- Richelson E. Pharmacology of antidepressants: characteristics of the ideal drug. Mayo Clin Proc 1994; 69(11): 1069–81
- Settle EC Jr. Bupropion: general side-effects. J Clin Psychiatr Monogr 1993; 11(1):33–9
- Stoudemire A. Expanding psycho- pharmacologic treatment options for the depressed medical patient. Psychosomatics 1995; 36(2):S19–26
- Kehoe WA, Schorr RB. Focus on mirtazapine: a new antidepressant with noradrenergic and specific serotonergic activity. Formulary 1996; 31(June):455–469
- Sisten JMA, Moors J. Mirtazapine: a novel antidepressant in the treatment of anxiety symptoms. Results from a placebo- controlled trial. Drug Invest 1994; 8(6): 339–44